ETF Holdings Breakdown of PACB

Stock NamePacific Biosciences of California
TickerPACB(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS69404D1081

News associated with PACB

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $2.45 Average PT from Brokerages
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average […] - 2025-05-06 05:30:47
Legal & General Group Plc Lowers Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)
Legal & General Group Plc lessened its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 6.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 234,635 shares of the biotechnology company’s stock after selling 16,736 shares […] - 2025-04-30 08:31:02
Geode Capital Management LLC Sells 64,981 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB)
Geode Capital Management LLC lowered its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 1.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 6,262,925 shares of the biotechnology company’s stock after selling 64,981 shares during the quarter. Geode Capital Management LLC’s holdings in Pacific Biosciences of California […] - 2025-04-23 07:26:51
Cibc World Markets Corp Makes New Investment in Pacific Biosciences of California, Inc. (NASDAQ:PACB)
Cibc World Markets Corp acquired a new stake in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 25,600 shares of the biotechnology company’s stock, valued at approximately $47,000. […] - 2025-03-28 08:18:45
Pacific Biosciences of California (NASDAQ:PACB) Price Target Cut to $2.00 by Analysts at Scotiabank
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) had its price objective lowered by analysts at Scotiabank from $6.00 to $2.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has a “sector outperform” rating on the biotechnology company’s stock. Scotiabank’s price target points to a potential upside of 57.48% from the […] - 2025-03-27 06:46:50
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Bought by New York State Common Retirement Fund
New York State Common Retirement Fund raised its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 299.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 84,725 shares of the biotechnology company’s stock after purchasing […] - 2025-03-06 10:56:56
Pacific Biosciences of California Sees Unusually High Options Volume (NASDAQ:PACB)
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) was the target of unusually large options trading activity on Tuesday. Investors acquired 31,944 call options on the stock. This represents an increase of approximately 477% compared to the typical volume of 5,533 call options. Wall Street Analyst Weigh In Several analysts have recently weighed […] - 2025-02-20 07:11:07

PACB institutional holdings

The following institutional investment holdings of PACB have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 175,689USD 210,827
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 33,505USD 40,206 5.8%
2025-05-08 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 339,177USD 407,012
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 138,088USD 165,706
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 138,088USD 165,706 5.8%
Total =824,547 USD 989,457
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.